138 related articles for article (PubMed ID: 36469798)
1. Cervical cancer screening history among women diagnosed with cervical cancer in Estonia 2017-18.
Orumaa M; Innos K; Suurna M; Veerus P
Eur J Public Health; 2023 Feb; 33(1):64-68. PubMed ID: 36469798
[TBL] [Abstract][Full Text] [Related]
2. Quality Assessment of Cervical Cytology Practices in Estonia From 2007 to 2018.
Orumaa M; Innos K; Suurna M; Salumäe L; Veerus P
Cancer Control; 2022; 29():10732748221141794. PubMed ID: 36542780
[TBL] [Abstract][Full Text] [Related]
3. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
[TBL] [Abstract][Full Text] [Related]
5. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
6. How many cervical cancer cases can potentially be prevented using a more sensitive screening test at young age?
de Kok IM; van Rosmalen J; Rozemeijer K; Penning C; van Ballegooijen M
Int J Cancer; 2014 Jan; 134(2):460-6. PubMed ID: 23824905
[TBL] [Abstract][Full Text] [Related]
7. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
8. Effect of Pap-smear and sociodemographic factors on cervical cancer risk in Estonia: A population-based case-control study.
Nõmm O; Veerus P; Orumaa M; Innos K
Cancer Epidemiol; 2022 Oct; 80():102231. PubMed ID: 35901623
[TBL] [Abstract][Full Text] [Related]
9. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
10. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
Bokan T; Ivanus U; Jerman T; Takac I; Arko D
Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
[TBL] [Abstract][Full Text] [Related]
11. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
Katki HA; Kinney WK; Fetterman B; Lorey T; Poitras NE; Cheung L; Demuth F; Schiffman M; Wacholder S; Castle PE
Lancet Oncol; 2011 Jul; 12(7):663-72. PubMed ID: 21684207
[TBL] [Abstract][Full Text] [Related]
13. Prevaccination Prevalence of Type-Specific Human Papillomavirus Infection by Grade of Cervical Cytology in Estonia.
Uusküla A; Oja M; Tamm S; Tisler A; Laanpere M; Padrik L; Nygard M; Reisberg S; Vilo J; Kolde R
JAMA Netw Open; 2023 Feb; 6(2):e2254075. PubMed ID: 36745455
[TBL] [Abstract][Full Text] [Related]
14. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
16. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
17. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
18. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
19. Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia.
Veerus P; Arbyn M; Amati C; Paolo B;
Tumori; 2010; 96(4):524-8. PubMed ID: 20968130
[TBL] [Abstract][Full Text] [Related]
20. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
